JOHNSON & JOHNSON (JNJ)

US4781601046 - Common Stock

154.35  -0.06 (-0.04%)

After market: 154.6 +0.25 (+0.16%)

JOHNSON & JOHNSON

NYSE:JNJ (5/26/2023, 7:04:00 PM)

After market: 154.6 +0.25 (+0.16%)

154.35

-0.06 (-0.04%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)04-18 2023-04-18/bmo
Earnings (Next)07-17 2023-07-17/bmo
Ins Owners0.07%
Inst Owners69.19%
Market Cap401.11B
Shares2.60B
PE15.18
Fwd PE13.92
Dividend Yield3.08%
Analysts71.54
IPO09-25 1944-09-25
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

JNJ Daily chart

Company Profile

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. The company is headquartered in New Brunswick, New Jersey and currently employs 152,700 full-time employees. The firm is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The company operates through three segments: Consumer Health, Pharmaceutical and MedTech. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The MedTech segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.

Company Info

JOHNSON & JOHNSON

One Johnson & Johnson Plaza

New Brunswick NEW JERSEY 08933

P: 17325242455.0

CEO: A. Gorsky

Employees: 152700

Website: https://www.jnj.com/

JNJ News

News Image15 hours ago - InvestorPlace7 Undervalued Blue-Chip Stocks to Buy for June 2023

These top undervalued blue-chip stocks offer a significant amount of upside as we get into the second half of 2023.

News Imagea day ago - The Motley FoolBuy the Dip On These Warren Buffett Stocks

You'll want to follow Buffett's lead and hold on to these stocks forever.

News Image2 days ago - Seeking AlphaWhy 2023 is turning into the year of the healthcare spinoff

Spinoffs are nothing new for publicly traded companies, but with the way things have gone in 2023, it could be a banner year for healthcare spinoffs. Read more here.

News Image3 days ago - Yahoo FinanceTylenol-Maker Kenvue Poised to Get Wall Street Ratings After IPO

(Bloomberg) -- Kenvue Inc., the consumer health business that Johnson & Johnson spun off this month, will be eligible for ratings from a slew of major Wall Street banks next week, offering a chance to see how analysts are assessing initial public offerings amid the latest equities volatility and recession worries. Most Read from BloombergEmerging US Debt Deal Would Raise Limit, Cap Spending for Two YearsCathie Wood’s ARKK Dumped Nvidia Stock Before $560 Billion SurgeEurope’s Economic Engine Is B

News Image3 days ago - BloombergTylenol-Maker Kenvue Poised to Get Wall Street Ratings After IPO

Kenvue Inc., the consumer health business that Johnson & Johnson spun off this month, will be eligible for ratings from a slew of major Wall Street banks next week, offering a chance to see how analysts are assessing initial public offerings amid the latest equities volatility and recession worries.

News Image3 days ago - InvestorPlace3 Dow Stocks Poised for a Roaring Relief Rally

Here are some compelling Dow stocks to buy if you believe the market may be on the cusp of a relief rally this summer.

JNJ Twits

Here you can normally see the latest stock twits on JNJ, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example